Core Viewpoint - The company is expected to see a significant improvement in its performance due to the favorable regulatory environment for vaping products and the growth of its heated non-combustible tobacco (HNB) business [1][2]. Financial Performance - For the first half of 2025, the company anticipates revenue of 6.013 billion yuan, representing an 18% year-on-year increase [1]. - The projected net profit for 2025H1 is between 443 million and 541 million yuan, indicating a year-on-year decline of 21% to 35%, with a midpoint decrease of 28% [1]. - Adjusted net profit, excluding stock incentive expenses, is expected to be between 688 million and 787 million yuan, reflecting a year-on-year change of -9% to +4%, with a midpoint of -2.5% [1][2]. Business Analysis - The company’s vaping business is benefiting from increased enforcement against illegal products in the U.S., with the FDA and customs seizing nearly 34 million USD worth of illegal e-cigarettes [1]. - The U.S. Senate has approved a 200 million USD budget for the FDA to combat illegal vaping products, indicating a positive regulatory trend for the compliant market [1]. - In Europe, the UK has banned disposable e-cigarettes, leading to a potential increase in sales of refillable products, which the company is well-positioned to capitalize on [1]. - The HNB product Glo hilo is currently in pilot sales in Serbia and Sendai, Japan, and is expected to contribute positively in the future [1]. Profitability Outlook - The company’s profitability is expected to improve due to a higher proportion of high-margin vaping products and the ongoing development of the HNB business [2]. - The adjusted profit margin is anticipated to show improvement, driven by the enhanced product mix in the vaping segment [2]. - The company is positioned uniquely in the market as the only listed entity deeply integrated into the supply chain of major overseas tobacco groups, which provides a competitive edge [2]. Earnings Forecast - The company projects earnings per share (EPS) of 0.21, 0.42, and 0.58 yuan for the years 2025 to 2027, with corresponding price-to-earnings (PE) ratios of 94, 48, and 34 times [2].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [5]. Core Views - The company is expected to benefit significantly from the ongoing crackdown on illegal vaping products in overseas markets, particularly in the U.S. and Europe, leading to an expansion of the compliant market [3][4]. - The company's adjusted net profit for the first half of 2025 is projected to be between 688-787 million yuan, reflecting a year-on-year change of -9% to +4% [2]. - The report highlights the improvement in the company's profitability due to a higher proportion of high-margin products in the vaping segment and the ongoing development of the HNB (Heat-not-Burn) business [4]. Financial Performance Summary - For the first half of 2025, the company is expected to achieve revenue of 6.013 billion yuan, representing an 18% year-on-year increase [2]. - The projected net profit for the first half of 2025 is estimated to be between 443-541 million yuan, indicating a year-on-year decline of 21% to 35% [2]. - The company's revenue is forecasted to grow from 11.168 billion yuan in 2023 to 19.693 billion yuan by 2027, with a compound annual growth rate (CAGR) of approximately 21.09% [10]. - The diluted earnings per share (EPS) are expected to be 0.21 yuan in 2025, increasing to 0.58 yuan by 2027 [5]. Business Segment Analysis - The vaping business is showing signs of recovery due to stricter regulations against illegal products, particularly in the U.S. where the FDA has intensified enforcement [3]. - The company is positioned uniquely as the only listed entity deeply integrated into the supply chain of both vaping and HNB products for major tobacco groups in overseas markets [4]. - The report anticipates that the company's product structure will continue to improve, leading to enhanced profitability in the vaping segment [4].